Optimus Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is SAFINAMIDE MESYLATE, with a corresponding US DMF Number 35138.
Remarkably, this DMF maintains an Active status since its submission on September 08, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 15, 2020, and payment made on August 27, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II